REILLY FINANCIAL ADVISORS, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$7,0000.0%5,0000.0%0.00%0.0%
Q4 2016$7,000
-22.2%
5,0000.0%0.00%
-50.0%
Q3 2016$9,000
+200.0%
5,000
+150.0%
0.00%
+100.0%
Q2 2016$3,000
-25.0%
2,0000.0%0.00%0.0%
Q1 2016$4,000
+300.0%
2,000
+300.0%
0.00%
Q3 2015$1,000
-50.0%
5000.0%0.00%
Q2 2015$2,0000.0%5000.0%0.00%
Q1 2015$2,0000.0%5000.0%0.00%
Q4 2014$2,0005000.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 10,500,000$17,955,0000.87%
SENZAR ASSET MANAGEMENT, LLC 1,872,191$3,201,447,0000.70%
Virtus ETF Advisers LLC 277,607$475,0000.35%
GLOBEFLEX CAPITAL L P 571,500$977,0000.27%
Lyons Wealth Management, LLC. 42,408$73,0000.11%
TFS CAPITAL LLC 222,736$381,0000.07%
Jacobi Capital Management LLC 35,000$56,0000.03%
Renaissance Technologies 5,601,355$9,578,0000.02%
WELLINGTON MANAGEMENT GROUP LLP 26,725,936$45,701,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 46,300$79,0000.01%
View complete list of ARENA PHARMACEUTICALS INC shareholders